JAGSONPAL PHARMACEUTICALS LTD

New Delhi-based Jagsonpal Pharmaceuticals recorded a revenue generation of Rs 21 crore in the biopharma space during FY 20-21, showing a growth of 8 per cent when compared to the revenue generated during FY 19-20 at Rs 19 crore. Founded in 1964, the company specialises in developing and manufacturing bulk drugs and pharmaceutical formulations. Besides India, It’s operations span Russia, Brazil, USA, Ukraine, Sri Lanka, Cameroon, Thailand, Argentina, Germany, Switzerland, Korea, Egypt & Vietnam. It has a robust portfolio of drugs focusing on women health, pain & analgesics & general medicine.